πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12419888

Methods of treating elevated plasma cholesterol

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11844771

Methods of treating acute respiratory distress syndrome using colchicine

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11795434

Engineered stem cells and cellular products produced and secreted by such cells, methods o

L'Institut de Cardiologie de MontrΓ©al Β· Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11639490

Device and method for producing and purifying exosomes

Foundation for Cardiological Research and Education (FCRE) Β· Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11529390

PCSK9 inhibitory polypolypeptides and methods of use

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11400063

Early administration of low-dose colchicine after myocardial infarction

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10788490

Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic ki

ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9789134

Agent for the selective adjustment of blood lipids

FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION β€œRESEARCH INSTITUTE FOR CARDIOLOGY” Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8729115

Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and met

CARDIOLYNX AG Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703098

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703800

Nitrate and diazeniumdiolate derivatives of pioglitazone

CARDIOLYNX AG Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8475764

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8426597

Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases

CARDIOLYNX AG Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030010

Method for detecting a biomarker of oxidative stress in a biological sample

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7235534

Antisense strategy to modulate estrogen receptor response (ER Ξ± and/or ER Ξ² )

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted